Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability

K Iwai, M Yaguchi, K Nishimura… - EMBO molecular …, 2018 - embopress.org
The modulation of pre‐mRNA splicing is proposed as an attractive anti‐neoplastic strategy,
especially for the cancers that exhibit aberrant pre‐mRNA splicing. Here, we discovered that …

Clinical outcomes with ring sideroblasts and SF3B1 mutations in myelodysplastic syndromes: MDS clinical research consortium analysis

Y Migdady, J Barnard, N Al Ali, DP Steensma… - … Myeloma and Leukemia, 2018 - Elsevier
Background Recurrent somatic mutations in SF3B1 have been identified in patients with
myelodysplastic syndromes (MDS) and are associated with ring sideroblasts (RS) and …

Novel mutations in mitochondrial carrier family gene SLC25A38, causing congenital sideroblastic anemia in Iranian families, identified by whole exome sequencing

M Mehri, M Zarin, F Ardalani, H Najmabadi… - Blood Cells, Molecules …, 2018 - Elsevier
Sideroblastic anemias are heterogeneous rare hematological disorders, representing
diverse phenotypes. In this study, the genetic cause of congenital, transfusion dependent …

[HTML][HTML] Alteration of SF3B1 and SRSF2 genes in myelodysplastic syndromes patients in upper northern Thailand

P Yimpak, A Tantiworawit… - Asian Pacific Journal …, 2019 - ncbi.nlm.nih.gov
Background: The frequency and pattern of mutation in SF3B1 and SRSF2 RNA splicing
machinery genes were found to vary among myelodysplastic syndrome (MDS) patients in …

[HTML][HTML] The frequency of SF3B1 mutations in Thai patients with myelodysplastic syndrome

P Rujirachaivej, T Siriboonpiputtana… - Asian Pacific Journal …, 2018 - ncbi.nlm.nih.gov
Genetic mutations in genes encoding critical component of RNA splicing machinery
including SF3B1 are frequently identified and recognized as the pathogenesis in the …

New developments in the understanding and diagnosis of myelodysplastic syndromes with ring sideroblasts

LB Ribeiro, EV De Paula - Revista Brasileira de Hematologia e …, 2016 - SciELO Brasil
Myelodysplastic syndromes (MDS) represent a group of clonal hematopoietic stem cell
disorders in which cytopenias of variable severity are associated with dysplastic changes of …